Marc Allard-Ratick

Interventional and Structural Cardiologist @GaHeart_NGHS || Trained @MGHHeartHealth || Former IM Resident / Chief Resident at Emory SOM and Grady

[Jonathan Reiner @JReinerMD]

I was up last night with a STEMI until 4:30. For my entire career I’ve gone to work the next day with whatever sleep I could get. Not anymore. Today, I slept in and did chart work from home. You can’t fly an airplane or drive a truck if you’ve been up all night. Why should it be different for docs?

[Marc Allard-Ratick @RatickM]

@DrJayMohan @TAVRBot @RadialFirstBot @BotPci @djc795 @PedroMDMSc @rwyeh @jaygirimd @DrRajeshG1 @RajTayalMD @rajivxgulati @TWilsonMD @ACCinTouch @JohnAFryMD If no angina I would leave it. The other thing to think about is if planning a BEV, you may crush an ostial stent when the valve is deployed so you need to have a wire down the artery with a balloon ready to go in case this happens. I am very rarely treating non LM lesions pre

[CircInterventions @CircIntv]

Hemodynamic performance of self-expanding transcatheter valve superior to balloon-expandable valve for small VIV-TAVR for failed small surgical aortic bioprosthesis. The 3-Year Results of the LYTEN Trial @PPibarot @luisnombela @ENofrerias @victoria_vilata https://t.co/WFDzdp0cR6

[Tayyab Shah @TayyabShahMD]

(1/2) Our study in @JACCJournals uses causal inference techniques to show that after @usnews TAVR ratings were released in 2020 there was a significant decline in the # of high risk AS patients receiving TAVR driven by lower rated hospitals.

https://t.co/56gpCMGyfb

[Marc Allard-Ratick @RatickM]

This combined with a subtweet directing people to see him in consult. The definition of a charlatan. One of the few very clear causative risk factors for coronary disease and it’s not in debate.

[Leo Lai, MBChB, FACC, FSCAI @LaiLeoDr]

Just published: Beyond Limits in Alternative Access: The Success of Right Subclavian Transcatheter Mitral Valve Replacement

https://t.co/tqabVP6z8e

@Brianponeill @PedroMDMSc @engelpedro @GKFram @AhmadJabri8

[Marc Allard-Ratick @RatickM]

@VictorDayan1 @pomyers @rafasadaba @STS_CTsurgery @EACTS Other published TAVR reintervention rates have been an order of magnitude lower than this….not saying I believe that over this but it’s just really odd. Something’s off.

[Marc Allard-Ratick @RatickM]

Wow…..very important progress being made for percutaneous valve retrieval in non-salvage TAVR cases

[Gennaro Giustino, MD @g_giustinoMD]

First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE)

Now in press in JACC CVI

Thank you to the patient/family and the Morristown team for the trust and support in me for this great save.

@PhilGenereuxMD

[Gennaro Giustino, MD @g_giustinoMD]

First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE)

Now in press in JACC CVI

Thank you to the patient/family and the Morristown team for the trust and support in me for this great save.

@PhilGenereuxMD

[Georgia Heart Institute @GaHeart_NGHS]

Interventional cardiologists with Georgia Heart Institute recently performed the first cases in the Southern United States using the SpectraWAVE HyperVue Imaging System. This system uses near-infrared "DeepOCT" and NIRS technology to capture highly detailed images from inside the coronary arteries. These images, powered by AI, help cardiologists make better-informed decisions to treat their patients. Kudos to Dr. Glen Henry, Dr. Stephane Rinfret and Dr. Olga Toleva and their team for bringing the future of heart care to our community — today! Learn more about our interventional cardiology program: https://t.co/6WP6BifTNV

[Marc Allard-Ratick @RatickM]

@ValerieAnne1970 This was answered in 2015 with a large randomized clinical trial that was funded by the NIH and NOT Big Pharma where lower target BP (120/80) was associated with a reduction in major adverse cardiovascular events. Stop spreading misinformation. https://t.co/zxvfsRPZQf

[Marc Allard-Ratick @RatickM]

Devastating. Dark times ahead….

[Farzad Mostashari @Farzad_MD]

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers.

I have never felt so intimidated by my peers

The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

[Ritu Thamman MD @iamritu]

Braunwald reverses 35 year old stance in asymptomatic severe aortic stenosis &AVR
https://t.co/M6fiEOkGNX

Don’t wait for symptoms to develop in severe AS!

No more “watchful waiting”
#justdoit Act & send patient for TAVR or SAVR @JAMACardio

[Marc Allard-Ratick @RatickM]

@AndreasRck2 That might be the worst root / STJ calcium I’ve ever seen

[Marc Allard-Ratick @RatickM]

@DrKene @YaleCardiology Congrats Kene!!!

[Marc Allard-Ratick @RatickM]

@Tesslagra The fact that mortality was significantly different between both groups suggests strongly to me that bias played a big role here. But I may just be limited to what I can see of the linked study.

[Marc Allard-Ratick @RatickM]

@Tesslagra This was a registry comparison….can we see differences between groups? Were those differences controlled for? How was femoral access performed (US guided vs conventional)? I couldn’t get any of these details from the study which would have significant impact on the result.

[Marc Allard-Ratick @RatickM]

@ColinDMcIntosh @itsdeaann Hell yeah Colin. Glad to see you’re doing well man!

[Marc Allard-Ratick @RatickM]

@SyedYNaqvi1 Wire both. Single stent back into the left main leaving enough room to POT. A good POT should be enough to avoid having to dilate the struts at the circ os in most situations.

[JACC Journals @JACCJournals]

LAMPOON enabled #TMVR despite the risk for #LVOT obstruction. There were no long-term complications assoc w/ LAMPOON. The selection of inoperable pts limited assessment of long-term survival following TMVR https://t.co/xRp0e6GxY0

#JACCINT @TheBethesdaLabs @CathElectroSurg @AdamGreenbaumMD @BabaliarosArgos @jamiemccabeMD